Remembering Rachna Shroff: The Sunshine She Leaves Behind
ESMO 2026 Metastatic Breast Cancer Guideline: Biomarker-Driven Therapy Reshapes Treatment Across Subtypes
What Comes Next? Treatment Sequencing in Advanced Urothelial Carcinoma
Legend Biotech Receives FDA IND Clearance for LB2501, a CD19/CD20 In Vivo CAR-T Therapy
Christopher Jackson: Humbled and Honoured to Receive the HRC’s Beaven Medal
"Stronger Regions, Stronger Countries..." - Dr Gevorg Tamamyan
Victor Moreno: Tumor Growth vs Antitumor Immunity, A New Strategy to Fight MSS Colorectal Cancer
Natalia Vilcu-Bajurean at LeukO 2026: A Mother's Powerful Promise to Change Childhood Cancer Care
OncoDaily IO is the dedicated immuno-oncology platform of OncoDaily, focused on the rapidly evolving science and clinical practice of cancer immunotherapy. It covers the full spectrum of immuno-oncology, including immune checkpoint blockade, cellular therapies, therapeutic cancer vaccines, antibody-based strategies, oncolytic viruses, next-generation immunomodulatory approaches, tumor microenvironment, immune biomarkers, neoantigens, treatment response and resistance, and personalized immunotherapy. Through OncoDaily IO, readers can follow the latest clinical trials, pivotal studies, translational research, regulatory decisions, emerging therapies, major congress highlights, and interviews with leading international experts advancing cancer prevention, control, and treatment through immunotherapy.
